September 12, 2022, President Biden signed the "Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe and Secure American Bioeconomy."1 Specified in that order is the development of genetic engineering.
ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins in the lab. The joint project has received over two million Swiss francs in funding from the Research Council of Norway and aims to produce an entirely new type of vein graft that could improve the lives of the millions of people suffering from deep venous insufficiency.